Shawn McKown, Benjamin Arnold, Frederique Boucher, Helena Correia, Sonya Eremenco, Tomislav Geršić, Melinda Johnson, Andriana Koumbarou, Igor Matias, Emily Parks-Vernizzi, Tim Poepsel, Jiyoung Son, Erin Strouse, C. B. Terwee & Mark Wade
Abstract
While there has been much discussion around the use of Artificial Intelligence (AI) for multilingual translations in other areas, recommendations pertaining specifically to the use of AI in the context of Clinical Outcome Assessment (COA) translation, linguistic validation, and electronic migration within clinical trials are lacking. Without published recommendations or guidelines, stakeholders involved in the COA translation process may be hesitant to explore or include AI. To address this gap, the AI Working Group of the ISOQOL TCA-SIG conducted a study to assess the landscape of AI in this specific context aimed at proposing recommendations for potential implementation of AI in COA translation, linguistic validation and electronic migration processes.
Read the full publication in its original format in The Journal of Patient-Reported Outcomes, here.
